{"symbol":"AMGN","provider":"yahoo-finance","fetchedAt":"2025-12-26T04:27:09.166Z","asOfDate":"2025-12-25","articles":[{"id":"1cc2f975-ad6b-348c-b50b-60e579b6245a","title":"Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026","url":"https://finance.yahoo.com/m/1cc2f975-ad6b-348c-b50b-60e579b6245a/dogs-of-the-dow-beat-the.html","publisher":"24/7 Wall St.","publishedAt":"2025-12-25T14:50:50.000Z","relatedTickers":["T","TMUS","VZ"],"mainIdea":"Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026","summary":"24/7 Wall St.: Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026. Keeping things simple when investing is often best, which is why buying an index fund can be the optimal strategy. Because the market has returned about 10% annually on average for the past 100 years, just buying an exchange-traded fund (ETF) could set an investor up for life. Yet you can do better than just ... Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026 Related tickers mentioned: T, TMUS, VZ."},{"id":"b24a246a-6397-39aa-9b8e-de96f1593f9d","title":"Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know","url":"https://finance.yahoo.com/news/amgen-strikes-drug-pricing-deal-153300363.html","publisher":"Zacks","publishedAt":"2025-12-24T15:33:00.000Z","relatedTickers":["BMY","GLAXF","GSK","MRK"],"mainIdea":"Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know","summary":"Zacks: Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know. AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment. Related tickers mentioned: BMY, GLAXF, GSK, MRK."},{"id":"4c3b6c72-7150-31dc-9ab3-543dbf8aeb04","title":"Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity?","url":"https://finance.yahoo.com/news/excited-amgen-inc-nasdaq-amgn-110023824.html","publisher":"Simply Wall St.","publishedAt":"2025-12-24T11:00:23.000Z","relatedTickers":[],"mainIdea":"Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity?","summary":"Simply Wall St.: Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity?. One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will..."},{"id":"db37c64f-c540-3db5-ad9c-e926111259bd","title":"Halozyme Therapeutics Stock Sees Relative Strength Rating","url":"https://finance.yahoo.com/m/db37c64f-c540-3db5-ad9c-e926111259bd/halozyme-therapeutics-stock.html","publisher":"Investor's Business Daily","publishedAt":"2025-12-23T17:42:32.000Z","relatedTickers":["HALO"],"mainIdea":"Halozyme Therapeutics Stock Sees Relative Strength Rating","summary":"Investor's Business Daily: Halozyme Therapeutics Stock Sees Relative Strength Rating. Halozyme Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating Related tickers mentioned: HALO."}]}
